Wenyan Kang

1.7k total citations
50 papers, 1.3k citations indexed

About

Wenyan Kang is a scholar working on Neurology, Molecular Biology and Physiology. According to data from OpenAlex, Wenyan Kang has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Neurology, 8 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Wenyan Kang's work include Parkinson's Disease Mechanisms and Treatments (30 papers), Neurological disorders and treatments (12 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). Wenyan Kang is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (30 papers), Neurological disorders and treatments (12 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). Wenyan Kang collaborates with scholars based in China, United States and Japan. Wenyan Kang's co-authors include Jun Liu, Shengdi Chen, Jianqing Ding, Mengyue Niu, Shengdi Chen, Yuanyuan Li, Linyuan Zhang, Tianfang Jiang, Lina Zhang and Aonan Zhao and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Wenyan Kang

49 papers receiving 1.3k citations

Peers

Countries citing papers authored by Wenyan Kang

Since Specialization

Citations

This map shows the geographic impact of Wenyan Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyan Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyan Kang more than expected).

Fields of papers citing papers by Wenyan Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyan Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyan Kang. The network helps show where Wenyan Kang may publish in the future.

Co-authorship network of co-authors of Wenyan Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyan Kang. A scholar is included among the top collaborators of Wenyan Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyan Kang. Wenyan Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single‐Molecule Insight Into α‐Synuclein Fibril Structure and Mechanics Modulated by Chemical Compounds 2025 ·Advanced Science ·(unknown), (unknown), Shenqing Zhang, (unknown), Wencheng Xia, Youqi Tao, (unknown), Yanan Li, Weidong Le, Wenyan Kang, Dan Li, Bo Sun, Cong Liu	1
2	The CXCR2 chemokine receptor: A new target for gastric cancer therapy 2024 ·Cytokine ·Wenyan Kang, Chengkun Wang, (unknown), (unknown), (unknown), (unknown), (unknown)	1
3	First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients 2024 ·The Journal of Headache and Pain ·Yang Zhao, Xiaodan Wang, Mengyue Niu, Wei Qiao, (unknown), (unknown), Weihong Yuan, (unknown), Shuo Zhu, (unknown), Jun Liu, (unknown), Wenyan Kang, (unknown)	3
4	Preoperative short‐course radiotherapy followed by chemotherapy and PD‐1 inhibitor administration for locally advanced rectal cancer: A study protocol of a randomized phase II/III trial (STELLAR II study) 2024 ·Colorectal Disease ·(unknown), Yuan Tang, Lichun Wei, Shixin Liu, Wenling Wang, Yihebali Chi, Ying Wang, Wenyan Kang, Wenting Huang, Fei‐Yan Deng, (unknown), Huiying Ma, Liming Jiang, (unknown), (unknown), Ye‐Xiong Li, Yinggang Chen, Haitao Zhou, Hu Chen, Jing Jin	2
5	The Role and Development of Peptide Vaccines in Cervical Cancer Treatment 2024 ·International Journal of Peptide Research and Therapeutics ·Minhui Wang, (unknown), Wenyan Kang, Xiaomin Liu, (unknown)	2
6	The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II study 2024 ·BMC Cancer ·(unknown), (unknown), (unknown), (unknown), Huiying Ma, (unknown), (unknown), Fei‐Yan Deng, Wenting Huang, Shuangmei Zou, Wenyan Kang, Liming Jiang, Ying Wang, Hu Chen, Yinggang Chen, Haitao Zhou, Yuan Tang, (unknown)	4
7	Halogen doped graphene quantum dots modulate TDP-43 phase separation and aggregation in the nucleus 2024 ·Nature Communications ·(unknown), Huazhang Guo, (unknown), Shujun Zhang, Shengnan Zhang, Wenyan Kang, Cong Liu, Weidong Le, Liang Wang, Dan Li, (unknown)	28
8	Clinical characteristics and outcome of COVID-19 patients with Parkinson’s disease: a hospital-based case–control study in Shanghai, China 2023 ·Frontiers in Aging Neuroscience ·Li Wu, Jun Shen, Yuhan Jiang, (unknown), Ping Wang, (unknown), Wenyan Kang, Jian‐Ren Liu, Wei Chen	2
9	Associations between polyunsaturated fatty acid concentrations and Parkinson’s disease: A two-sample Mendelian randomization study 2023 ·Frontiers in Aging Neuroscience ·(unknown), (unknown), Wenyan Kang, Peizhan Chen, Jun Liu	17
10	Impaired Ocular Tracking and Cortical Atrophy in Idiopathic Rapid Eye Movement Sleep Behavior Disorder 2022 ·Movement Disorders ·(unknown), (unknown), (unknown), Zhichun Chen, Lina Zhang, Haiyan Zhou, Wenyan Kang, Xufeng Jiang, Yuanyuan Li, (unknown), (unknown), Mengyue Niu, Shengdi Chen, Xi‐Nian Zuo, Li Li, Jun Liu	5
11	Efficacy of idebenone in the Treatment of iRBD into Synucleinopathies (EITRS): rationale, design, and methodology of a randomized, double-blind, multi-center clinical study 2022 ·Frontiers in Neurology ·Yuanyuan Li, Chunyi Wang, (unknown), Fangzheng Chen, (unknown), Mengyue Niu, Wenyan Kang, Jun Liu	7
12	A longitudinal study on α‐synuclein in plasma neuronal exosomes as a biomarker for Parkinson’s disease development and progression 2020 ·European Journal of Neurology ·Mengyue Niu, Yang Li, Gerald Li, Lin Zhou, (unknown), Ming Yao, Wenyan Kang, Jianjun Liu	131
13	DJ-1 Inhibits α-Synuclein Aggregation by Regulating Chaperone-Mediated Autophagy 2017 ·Frontiers in Aging Neuroscience ·Chuanying Xu, Wenyan Kang, Yimeng Chen, Tianfang Jiang, Jia Zhang, Lina Zhang, Jianqing Ding, Jun Liu, Shengdi Chen	111
14	Hyposmia Is Associated with RBD for PD Patients with Variants of SNCA 2017 ·Frontiers in Aging Neuroscience ·Yuanyuan Li, Wenyan Kang, Linyuan Zhang, (unknown), Mengyue Niu, Jun Liu	14
15	Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients 2016 ·Scientific Reports ·Wenyan Kang, Wei Chen, Qiong Yang, Lina Zhang, Linyuan Zhang, Xiaoying Wang, Fangyi Dong, Yang Zhao, Daiwen Chen, Thomas J. Quinn, Jing Zhang, Shengdi Chen, Jun Liu	64
16	Association of rapid eye movement sleep behavior disorder with sleep-disordered breathing in Parkinson's disease 2016 ·Sleep Medicine ·Linyuan Zhang, Wenyan Liu, Wenyan Kang, Qiong Yang, Xiaoying Wang, Jianqing Ding, Shengdi Chen, Jun Liu	32
17	Association study of α-synuclein gene polymorphism and non motor symptoms in Parkinson's disease 2015 ·Guoping Wu, (unknown), Wenyan Kang, Jun Liu	1
18	P2X7 receptor is critical in α-synuclein–mediated microglial NADPH oxidase activation 2015 ·Neurobiology of Aging ·Tianfang Jiang, Jake G. Hoekstra, Xin Heng, Wenyan Kang, Jianqing Ding, Jun Liu, Shengdi Chen, Jing Zhang	105
19	Salivary DJ-1 could be an indicator of Parkinson's disease progression 2014 ·Frontiers in Aging Neuroscience ·Wenyan Kang, Qiong Yang, Xufeng Jiang, Wei Chen, Linyuan Zhang, Xiaoying Wang, Lina Zhang, Thomas J. Quinn, Jun Liu, Shengdi Chen	46
20	Application of odor identification test in Parkinson's disease in China: A matched case-control study 2012 ·Journal of the Neurological Sciences ·Wei Chen, (unknown), Wenyan Kang, Bo Li, Zhimin Xu, Qin Xiao, Jun Liu, Ying Wang, Gang Wang, Shengdi Chen	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact